JPMorgan China Growth & Income Outperforms Benchmark Despite Volatility, Raises Dividend 24%

JPMorgan China Growth & Income PLC has delivered one of those updates that is both uncomfortable and encouraging at the same time. The uncomfortable bit is obvious: shareholders saw the portfolio fall over the six months to 31 March 2026. The encouraging bit is that it still did materially better than the wider China market, lifted its planned annual dividend by 24%, and continued buying back shares at a discount.

For investors in this trust, that combination matters. It suggests the managers are not pretending the backdrop is easy, but they are showing enough stock-picking skill to lose less than the benchmark and keep backing the income story.

JPMorgan China Growth & Income half-year results: the key numbers investors need

Metric	Six months to 31 March 2026
NAV total return	-9.5%
MSCI China Index return	-13.9%
Share price total return	-8.5%
Discount to NAV	9.0% from 9.7%
Net asset value per share	300.4p
Planned fourth interim dividend	3.39p
Expected annual dividend	13.56p
Dividend increase year on year	24%
Shares bought back in period	1,009,596
Shares bought back since period end	1,481,285

Benchmark outperformance in a falling market is the big message here

The headline return was weak, with NAV, or net asset value, down 9.5% in sterling terms. NAV is the underlying value of the trust’s assets minus liabilities, so it is usually the cleanest way to judge manager performance. On the face of it, a near 10% drop is not pretty.

But context matters. The MSCI China Index fell 13.9%, so the trust outperformed by 4.4 percentage points. In a market as volatile as China has been, losing less than the benchmark is not a trivial achievement.

Management says stock selection added 7.6 percentage points relative to the benchmark, while sector allocation cost 2.0 points and gearing cost 1.9 points. Gearing simply means borrowing or using financial tools to increase market exposure. That can boost gains in rising markets, but it hurts when markets fall, which is exactly what happened here.

My read is that this is a credible half-year. Not because the absolute performance was good – it was not – but because the trust seems to be getting the important thing right again after a rough patch: picking better stocks than the index.

Why the 24% dividend increase matters for income investors

The planned fourth interim dividend is 3.39p per share, which would take the annual payout for the year ending 30 September 2026 to 13.56p per share. That is up from 10.92p last year, a 24% increase.

That is a strong statement of intent. This trust is not just trying to give investors access to Chinese growth shares – it is also trying to provide a meaningful income stream. The board says the increase reflects the improved NAV during the previous financial year.

There is one nuance worth knowing. The report states that dividend payments in excess of revenue can be paid out of distributable capital reserves. In plain English, some of the dividend does not have to come purely from natural income generated by the portfolio. That is common for some investment trusts, but investors should understand it because it can make payouts smoother even when market conditions are choppy.

Share buybacks, discount control and why the narrowing gap matters

The share price discount narrowed from 9.7% to 9.0% over the period. A discount means the shares trade below the trust’s NAV. For existing shareholders, a narrower discount is usually a positive because it means the market is valuing the trust a little more generously.

The board bought back 1,009,596 shares during the six-month period at an average discount of 10.4%. Since the period end, it has bought back another 1,481,285 shares at an average discount of 10.3%.

I think that is sensible capital allocation. When an investment trust’s shares trade materially below asset value, buybacks can enhance NAV per share for remaining investors. They are not a magic wand, but they are a useful tool, and this board is clearly willing to use them.

Tencent, China A shares and the portfolio changes shaping returns

One of the more interesting developments is the approved change in investment restrictions. The maximum permitted exposure to a single company is now the lower of a 5% position over the benchmark or 20% of net assets. That gave the managers room to add to Tencent, which ended the period at 16.9% of the portfolio.

That is a big position, so conviction is clearly high. The managers describe Tencent as core digital infrastructure in China, spanning social media, gaming, payments, content and cloud. If they are right, it could be a major driver of future returns. If they are wrong, concentration risk becomes more noticeable.

The trust also had 42% of the portfolio in China A shares, which are mainland-listed shares in Shanghai and Shenzhen. That exposure helped because those markets were more resilient than offshore Hong Kong stocks during the period.

Among positive contributors were Taiwan Semiconductor Manufacturing Company, MPI, WUS Printed Circuit, Minimax, Sieyuan Electric and H World. On the negative side, Didi, Trip.com, Kuaishou, CATL and Shenzhen Inovance hurt performance. That mix tells you the trust is leaning hard into technology, AI-linked names and industrial growth themes rather than taking a broad-brush approach.

Gearing, CFDs and the main risks in this China investment trust

Gearing stood at 12.3% at 31 March 2026, down from a peak range high of 16.7% during the period. The trust uses Contracts for Difference, or CFDs, to provide gearing. CFDs are derivatives that give exposure to share price movements without owning the shares directly. They are capital efficient, but they add complexity and risk.

That is worth noting because the financial statements show a £10.610 million loss on derivative financial instruments in the half year. Total net loss after taxation was £26.450 million, compared with a profit of £9.116 million in the equivalent period last year.

The risk list is long and very real: geopolitics, China-US tensions, tariffs, the Middle East conflict, the closure of the Strait of Hormuz, cyber risk and discount risk among others. This is not a sleepy income fund. It is a China-focused investment trust using gearing in a market that can move sharply.

China outlook in 2026: stabilising economy, but plenty can still go wrong

The board and managers sound more upbeat on China than many investors probably feel. They point to first-quarter 2026 GDP growth of 5%, a 14.7% surge in exports, improving business confidence and government support through the new Five-Year Plan.

They also argue Chinese valuations remain below historical averages and that the economy is better positioned than many peers to deal with energy disruption thanks to diversification. That is the optimistic case, and it is not hard to see why the managers remain constructive.

The catch is that domestic consumer sentiment is still subdued, geopolitical uncertainty remains high, and global oil market disruption could still filter through into costs and confidence. So yes, there is a recovery argument here, but it is far from risk-free.

My verdict on JPMorgan China Growth & Income’s half-year report

This is a better update than the negative headline numbers first suggest. A 9.5% NAV decline is never fun, but outperforming the benchmark by 4.4 percentage points, narrowing the discount, increasing the planned annual dividend to 13.56p, and continuing buybacks all point to a trust that is being actively managed with some purpose.

The positives are clear: improving relative performance, strong long-term numbers, with a ten-year NAV total return of 107.9% against 78.7% for the benchmark, and a more generous income payout. The negatives are also clear: China remains volatile, gearing adds risk, and the trust is making some fairly concentrated bets.

For retail investors, the takeaway is simple. If you already own this trust, the half-year report offers some reassurance that performance versus the market is improving. If you are considering buying, this still looks like a higher-risk way to play a potential China recovery, but at a 9.0% discount and with a rising dividend, it is at least giving investors a few solid reasons to stay interested.